CS269993B2 - Method of 5-chloro-7-iodo-8-hydroxyquinoline's pharmaceutically pure zinc complex preparation - Google Patents

Method of 5-chloro-7-iodo-8-hydroxyquinoline's pharmaceutically pure zinc complex preparation Download PDF

Info

Publication number
CS269993B2
CS269993B2 CS872035A CS203587A CS269993B2 CS 269993 B2 CS269993 B2 CS 269993B2 CS 872035 A CS872035 A CS 872035A CS 203587 A CS203587 A CS 203587A CS 269993 B2 CS269993 B2 CS 269993B2
Authority
CS
Czechoslovakia
Prior art keywords
zinc
chloro
iodo
hydroxyquinoline
complex
Prior art date
Application number
CS872035A
Other languages
Czech (cs)
English (en)
Other versions
CS203587A2 (en
Inventor
Gyula Dr Sebestyen
Istvan Dr Simonyi
Gizella Dr Miholics
Marta Dr Kovacs
Frigyes Dr Gorgenyi
Marton Dr Fekete
Pal Dr Vago
Istvan Seres
Janos Egri
Maria Szeli
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of CS203587A2 publication Critical patent/CS203587A2/cs
Publication of CS269993B2 publication Critical patent/CS269993B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C07D215/30—Metal salts; Chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CS872035A 1986-04-18 1987-03-25 Method of 5-chloro-7-iodo-8-hydroxyquinoline's pharmaceutically pure zinc complex preparation CS269993B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU861623A HU196554B (en) 1986-04-18 1986-04-18 Process for production of medical compounds with fungicidal effect

Publications (2)

Publication Number Publication Date
CS203587A2 CS203587A2 (en) 1989-04-14
CS269993B2 true CS269993B2 (en) 1990-05-14

Family

ID=10955373

Family Applications (1)

Application Number Title Priority Date Filing Date
CS872035A CS269993B2 (en) 1986-04-18 1987-03-25 Method of 5-chloro-7-iodo-8-hydroxyquinoline's pharmaceutically pure zinc complex preparation

Country Status (24)

Country Link
US (2) US4868172A (da)
JP (1) JPS62294616A (da)
KR (1) KR870010036A (da)
CN (1) CN1021632C (da)
AU (1) AU601725B2 (da)
BE (1) BE1001251A4 (da)
BG (1) BG47945A3 (da)
CA (1) CA1306685C (da)
CH (1) CH671880A5 (da)
CS (1) CS269993B2 (da)
DE (1) DE3713372A1 (da)
DK (1) DK200087A (da)
ES (1) ES2005165A6 (da)
FI (1) FI871703A (da)
FR (1) FR2597343B1 (da)
GB (1) GB2189144B (da)
GR (1) GR870617B (da)
HU (1) HU196554B (da)
IL (1) IL82238A0 (da)
IT (1) IT1207583B (da)
NL (1) NL8700906A (da)
PL (1) PL265249A1 (da)
SE (1) SE8701592L (da)
YU (1) YU46313B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0355383A1 (de) * 1988-07-28 1990-02-28 Ciba-Geigy Ag Solubilisierungsverfahren
US5219847A (en) * 1989-06-12 1993-06-15 Shiseido Company, Ltd. Antipruritic composition
CA2033335A1 (en) * 1989-06-12 1990-12-13 Chuji Yanagawa Antipruritic composition
US7846919B2 (en) * 1998-02-10 2010-12-07 Dermex Pharmaceuticals, Llc Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions
EP2643060A4 (en) * 2010-11-25 2018-03-07 Zza Key Technologies Ltd Biodegradable fire-fighting formulation
CN111937886A (zh) * 2019-05-16 2020-11-17 兰州大学 一种8-羟基喹啉配合物的制备及其在防治植物病害中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH494760A (de) * 1962-11-30 1970-08-15 Metalsalts Corp Verfahren zur Herstellung von Metall-8-chinolinolaten mit Ausnahme der Alkalimetallderivate
US3886277A (en) * 1967-02-14 1975-05-27 Schwarzkopf Gmbh Hans Methods of controlling dandruff using 5,7-dichloro-8-hydroxy quinoline
BE755584A (fr) * 1969-09-19 1971-03-01 Ugine Kuhlmann Nouveaux medicaments a activite amoebicide
DE2154020A1 (de) * 1971-10-29 1973-05-03 Hoechst Ag Metallkomplexe von substituierten benzimidazolen
NO156672C (no) * 1975-10-24 1987-11-04 Chapman Chem Co Preparat med antimikrobiell og eventuelt insekticid virkning og anvendelse av et slikt preparat som tre- og vekstbeskyttelsesmiddel.
ZA786259B (en) * 1977-11-09 1979-10-31 Procter & Gamble Therapeutic composition
DE3129685C2 (de) * 1981-07-28 1986-11-06 geb. Stoffel Annemarie Dr. 7802 Merzhausen Buck Antiseptische Lösung

Also Published As

Publication number Publication date
DK200087A (da) 1987-10-19
ES2005165A6 (es) 1989-03-01
AU601725B2 (en) 1990-09-20
DK200087D0 (da) 1987-04-15
GB8709166D0 (en) 1987-05-20
FI871703A0 (fi) 1987-04-16
YU69387A (en) 1988-12-31
KR870010036A (ko) 1987-11-30
US4868172A (en) 1989-09-19
JPH0525858B2 (da) 1993-04-14
HUT43781A (en) 1987-12-28
DE3713372C2 (da) 1991-12-19
IL82238A0 (en) 1987-10-30
SE8701592D0 (sv) 1987-04-16
AU7175887A (en) 1987-10-22
YU46313B (sh) 1993-05-28
CS203587A2 (en) 1989-04-14
GR870617B (en) 1987-08-18
FI871703A (fi) 1987-10-19
CH671880A5 (da) 1989-10-13
FR2597343B1 (fr) 1991-11-29
BG47945A3 (en) 1990-10-15
DE3713372A1 (de) 1987-10-22
SE8701592L (sv) 1987-10-19
GB2189144A (en) 1987-10-21
BE1001251A4 (fr) 1989-09-05
JPS62294616A (ja) 1987-12-22
IT8720168A0 (it) 1987-04-17
CN1021632C (zh) 1993-07-21
PL265249A1 (en) 1988-07-21
HU196554B (en) 1988-12-28
NL8700906A (nl) 1987-11-16
FR2597343A1 (fr) 1987-10-23
CA1306685C (en) 1992-08-25
CN87102747A (zh) 1987-12-09
IT1207583B (it) 1989-05-25
US4871728A (en) 1989-10-03
GB2189144B (en) 1990-04-25

Similar Documents

Publication Publication Date Title
US5350582A (en) Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof
US6288045B1 (en) Epithelial cell cancer drug
US4196217A (en) Hydroxylated amines with bacteriostatic activity
WO1993001203A1 (en) Antifungal amphotericin derivative
CS269993B2 (en) Method of 5-chloro-7-iodo-8-hydroxyquinoline's pharmaceutically pure zinc complex preparation
CA1297033C (en) Use of carboxylic acid amides for treating inflammations
WO2000003709A9 (en) Novel dna-cleaving antitumor agents
IE47417B1 (en) Pyridine derivative
JPS6377895A (ja) １１−アザ−１０−デオキソ−１０−ジヒドロエリスロマイシンａ又はそのｎ−メチル誘導体の金属錯塩及びそれらの製造法
US4144328A (en) N,N,N-Trimethyl derivatives of polyene amphoteric antibiotics, process of producing same and pharmaceutical composition
RU2084449C1 (ru) 1-бензил-2-оксотриптамин гидрохлорид и его производные, обладающие гепатозащитной активностью
FI80036C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 4-klor-furo-(3,4-c)-pyridinderivat.
US20090162448A1 (en) Metal Carbonate Particles and Methods of Making Thereof
EP0200527A2 (en) Norfloxacin salt
JPS63284186A (ja) ４−トリアルキルシリルベンジルアミン誘導体、その製造法及び用途
JP3348849B2 (ja) ３−ヒドロキシ−４−ピロンのガリウム錯体の医薬組成物
US4377583A (en) N-Methyl-D-glucamine salt of with 3,4-dihydro-5-methyl-6-(2-methylpropyl)-4-oxothieno[2,3-d]pyrimidine-2-carboxylic acid
DE2706841C2 (da)
US3147246A (en) Obtention of an alkaloid from nuphar luteum
CA1301776C (en) Compound of choline, a process for its preparation and therapeutic composition containing it
RU1824396C (ru) Пиперидиламид 3,5-дибром-4-аминобензолсульфонилсукцинаминовой кислоты, про вл ющий нейролептическое и мочегонное действие
RU2032660C1 (ru) Способ получения комплексов на основе ациклических аминов, обладающих радиопротекторными свойствами
US3960882A (en) Chemical compounds for trichomoniasis and candidiosis treatment
CS276842B6 (en) Pharmaceutical
DE2625585A1 (de) 6-aminomethylierte, 3-oxygenierte cholest-5-ene und verfahren zu ihrer herstellung